PKM and urinary bladder cancer: Wang et al. demonstrated that, in bladder cancer cells, the elevation of ALYREF, activated by HIF-1α, stabilizes PKM2 mRNA via m5C modification and promotes bladder cancer cell proliferation by PKM2-mediated glycolysis [29].